← FDA Drug Approvals (Drugs@FDA)

PROGRAF

NDA · New Drug Application · Sponsor: ASTELLAS · Approved 2018-05-24

Drug application

FDA Application #

NDA210115

Application type

New Drug Application

Brand name

PROGRAF

Generic name

TACROLIMUS

Active ingredients

TACROLIMUS

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

ASTELLAS

Manufacturer

Astellas Pharma US, Inc.

First approval

2018-05-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown